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variables, REBOA-specific data, complications and 30-days 
mortality were reported.
Results Ninety-six cases from 6 different countries 
were reported between 2011 and 2016. Mean age was 
52 ± 22 years and 88% of the cases were blunt trauma with a 
median injury severity score (ISS) of 41 (IQR 29–50). In the 
majority of the cases, Zone I REBOA was used. Median sys-
tolic blood pressure before balloon inflation was 60 mmHg 
(IQR 40–80), which increased to 100 mmHg (IQR 80–128) 
after inflation. Continuous occlusion was applied in 52% 
of the patients, and 48% received non-continuous occlu-
sion. Occlusion time longer than 60 min was reported as 
38 and 14% in the non-continuous and continuous groups, 
respectively. Complications, such as extremity compartment 
Abstract 
Purpose Resuscitative endovascular balloon occlusion of 
the aorta (REBOA) is a technique for temporary stabiliza-
tion of patients with non-compressible torso hemorrhage. 
This technique has been increasingly used worldwide during 
the past decade. Despite the good outcomes of translational 
studies, clinical studies are divided. The aim of this multi-
center-international study was to capture REBOA-specific 
data and outcomes.
Methods REBOA practicing centers were invited to join 
this online register, which was established in September 
2014. REBOA cases were reported, both retrospective and 
prospective. Demographics, injury patterns, hemodynamic 
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syndrome (n = 3), were only noted in the continuous occlu-
sion group. The 30-day mortality for non-continuous 
REBOA was 48%, and 64% for continuous occlusion.
Conclusions This observational multicenter study presents 
results regarding continuous and non-continuous REBOA 
with favorable outcomes. However, further prospective stud-
ies are needed to be able to draw conclusions on morbidity 
and mortality.
Keywords Aortic occlusion · Trauma · REBOA · IABO · 
Hemorrhage
Abbreviations
NCTH  Non-compressible torso hemorrhage
DCR  Damage control resuscitation
REBOA  Resuscitative endovascular balloon occlusion 
of the aorta
PRBC  Packed red blood cells
FFP  Fresh frozen plasma
PLT  Platelets
CPR  Cardiopulmonary resuscitation
GCS  Glasgow coma scale
SBP  Systolic blood pressure
ISS  Injury severity score
ER  Emergency room
MOF  Multiple organ failure
MAP  Mean arterial pressure
pREBOA  Partial resuscitative endovascular balloon 
occlusion of the aorta
iREBOA  Intermittent resuscitative endovascular balloon 
occlusion of the aorta
CO  Continuous occlusion
NCO  Non-continuous occlusion
Introduction
Non-compressible torso hemorrhage (NCTH) is a challenge 
for trauma clinicians worldwide. Despite advances in the 
delivery of trauma care, such as damage control resuscitation 
(DCR) and the formalization of trauma systems, mortality 
from exsanguination remains as high as 45% [1]. Hemor-
rhage control and resuscitation are key management prin-
ciples; however, these can be difficult to deliver in a timely 
manner and are often logistically complex.
Resuscitative endovascular balloon occlusion of the aorta 
(REBOA) is a technique whereby a compliant balloon is 
temporarily inflated in the aorta, thereby reducing distal 
blood flow and increasing cardiac afterload [2–4]. This 
hemodynamic profile is highly advantageous to bleeding 
patients; thus, REBOA has been proposed as a temporizing 
adjunct in the management of NCTH until definitive inter-
vention can be achieved [5, 6].
However, this is controversial, as REBOA delivery 
requires specialist training, and balloon deflation can be 
associated with significant ischemia–reperfusion injury. 
The current evidence base is weak, with studies showing 
both good and bad outcomes, although data have often been 
drawn from registries conceived for different purposes or 
studies reporting small numbers of cases [7, 8].
In an effort to overcome these shortcomings, the Aortic 
Balloon Occlusion Trauma Registry (ABO Trauma Registry; 
www.abotraumaregistry.com) was established in 2014, with 
the goal of capturing REBOA-specific data from centers 
using this adjunct across the world. While still in a nascent 
form, the aim of the current study is to present the initial 
findings of the registry and patient outcomes.
Methods
Registry overview
The ABO Trauma Registry is designed to provide a mech-
anism for retrospective and prospective data capture for 
trauma patients in hemorrhagic shock, where management 
includes the use of REBOA. Center recruitment is ad hoc, 
with known REBOA-practicing institutions invited to par-
ticipate directly, but centers can also register independently, 
via the registry website after approval from the investigators.
To capture clinically pragmatic data, there are no center-
specific criteria, such as minimum case volume or hospital 
size. The registry is funded and hosted by the Department 
of Cardiothoracic and Vascular Surgery, Örebro University 
Hospital, Sweden.
Ethical permission and data security
Prior to accepting cases, ethical approval was obtained from 
the regional committee (study number: 2014/210; Uppsala, 
Sweden). Participating centers also had to obtain approval 
from their local ethics committee.
Patient data are anonymized at the point of registration 
with a unique registry-generated ID number; no patient iden-
tifiable data, such as date of birth, are held. All data are held 
on a secure electronic database, and a secured password has 
been given to centers joining the registry to be able to enter 
data.
Data collection
Collection is made via the website and includes data pertain-
ing to demographics, mechanism of injury, vital signs and 
Glasgow coma scale (GCS) prehospital and on admission, 
laboratory tests, injury severity score (ISS), systolic blood 
pressure (SBP) before and after REBOA inflation, REBOA 
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and non-REBOA interventions, puncture technique, speci-
ality obtaining access, number of access attempts, zone of 
occlusion, occlusion time, and resuscitation.
Transfusion size per unit for blood products varies 
between countries. To be able to calculate the amount of 
transfusions, units were converted into Swedish transfusion 
sizes; 300 ml/packed red blood cells (PRBC), 250 ml/fresh 
frozen plasma (FFP) and 250 ml/platelets (PLT).
Further variable analysis was done on REBOA-specific 
data related to the length of occlusion, zones of occlusion 
and the REBOA technique employed. The zones of REBOA 
occlusion have been defined previously, but in brief: zone I 
extends from the origin of the left subclavian artery to the 
celiac trunk, zone II is from the celiac trunk to the lowest 
renal artery, and zone III involves the infrarenal aorta [3].
REBOA techniques have been defined as continuous (CO) 
or non-continuous (NCO). A CO technique is described as 
using a balloon fully inflated from insertion for the entire 
duration of its use, and only deflated once it is no longer 
required clinically. This is in contrast to NCO REBOA 
techniques, which are a heterogeneous group of techniques, 
such as partial or intermittent inflation. Partial REBOA 
(pREBOA) is where the balloon volume is reduced to per-
mit a level of flow-through, whereas intermittent occlusion 
(iREBOA) is where the balloon is deflated entirely at regular 
intervals [9–12]. Both these techniques have been described 
as strategies to ameliorate ischemia–reperfusion injury. 
There is no universally accepted definition of these terms, so 
we have elected to describe this group as “non-continuous” 
REBOA techniques to avoid ambiguity.
Complication data were collected in relation to REBOA 
management, such as balloon migration/rupture, aortic 
rupture, puncture site hemorrhage, extremity compartment 
syndrome, and distal embolus, but there are also general 
complications, such as organ failure. Finally, patient out-
come was defined as 30-day mortality.
Data analysis
Continuous data are presented using mean ± standard devia-
tion or median and interquartile range (25th–75th percen-
tiles), depending on data distribution. Binary and nominal 
data are presented using numbers and proportions of avail-
able data due to missing information. A simple univariate 
comparison between survivors and fatalities was made; how-
ever, due to anticipated low numbers, multivariate analy-
sis was not planned for this report. Continuous data were 
compared using a Student t test or Mann–Whitney U test, 
and categorical data using a Chi squared test. Paired t test 
and Wilcoxon’s test were used for comparison of pre- ver-
sus post-REBOA inflation. Significance was set at p < 0.05. 
Statistical analysis was completed using IBM SPSS version 
23.0 (Armonk, NY, USA).
Results
Registry overview
Data were collected retrospectively from November 2011 
and prospectively sampled from September 2014 until the 
end of September 2016. A total of 99 cases were registered: 
38 prospective and 61 retrospective from 13 different hos-
pitals within 6 countries (Fig. 1). However, 3 patients were 
excluded for having not met the inclusion criteria: REBOA 
was used in non-traumatic shock (n = 1), the balloon was not 
deployed due to access difficulties (n = 1), and the balloon 
was not inflated (n = 1). A total of 96 patients remained in 
the analysis (Table 1).
Patient characteristics, injury patterns and admission 
physiology
Sixty-four cases (67%) were reported from Japan. The 
mechanism of injury was blunt trauma in 88% (84/95) of 
the patients, and the mean age was 52 ± 22 yrs. Most of 
the patients (68%) were males without reported comorbidity 
(53%), with a median injury severity score (ISS) of 41 (IQR 
29–50) (Table 1). The most common injuries were located 
in the abdomen (liver, spleen, major abdominal vessels) and 
pelvis.
Cardiopulmonary resuscitation (CPR) was performed at 
the injury site in 20% of the patients (18/91) and was ongo-
ing through to the Emergency room (ER) in 14% (11/79) of 
the reported cases. The prehospital GCS score was >8 in 
63% (47/75) of the cases, and 40% (36/91) were reported to 
have a head injury (Table 1). Pupillary response was absent 
in 10 out of 37 reported patients, and 90% of those patients 
died within 30 days. Intubation was performed in the ER in 
64% (35/55) of the patients, and 90% (86/96) survived the 
ER (Table 1).
On admission, 66% (43/65) were in deep hemodynamic 
shock with a SBP of <80  mmHg. Median SBP before 
REBOA was 60  mmHg (IQR 40–80), which increased 
to 100 mmHg (IQR 80–128) immediately after balloon 
inflation in the hospital. SBP was higher in the survival 
group compared to the fatalities, before and after inflation 
(p < 0.05; Tables 1, 2).
Methods and location of arterial access
In the majority of the cases (66%, 58/88), femoral access was 
achieved in the emergency room, followed by the operat-
ing room or the hybrid operating room to the same extents. 
The puncture method was blind puncture in 84% of cases 
(71/85), and was mostly conducted by emergency/intensive 
care physicians (67%, 60/90). Access was established on the 
primary attempt in 55% (32/58) of the cases. (Table 2). The 
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Fig. 1  Location
Legend Location REBOA Cases 
A Kirov Military Medical Academy, 7 
Russian Federation 
B Örebro University Hospital, Sweden 13 
C 
Hillel Yaffe Medical Centre, 
3 
 Israel  
D Dzhanelidze Research Institute of Emergency Medicine, Russian Federation 1 
E 
Sahlgrenska University Hospital, 
3 
Sweden 
F Västmanlands Hospital Västerås, Sweden 1 
G Helsinki University Hospital, Finland 3 
H Senshu Trauma and Critical Care, Japan 12 
I Hachinohe City Hospital, Japan 22
J Ohta Nishinouchi Hospital, Japan 26
K Chiba University Graduate School of medicine, Japan 2 
L St Marianna University School of Medicine, Japan 2 
M 
Papa Giovanni XXIII Hospital,
1 
Italy
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most frequently used sheaths were 7 Fr (39%, 35/91) mostly 
used in Japan, followed by 10 and 11 Fr, used frequently in 
other countries.
REBOA procedure
Zone I occlusion was used in 94% of patients (Table 2). 
Adjustment of the occlusion level was made in 34% of the 
62 reported cases (for different reasons). There were 6 cases 
where adjustment was made to a different zone, mostly from 
zone I to III. One adjustment was due to balloon migration. 
The rest of the adjustments, 14 cases, were within the same 
zone.
Methods of definitive hemostasis, resuscitation 
and critical care
Thoracotomy was performed in 29 patients of whom 21 
underwent aortic clamping, with 86% mortality. Aor-
tic clamping was performed before REBOA insertion in 
these cases. Laparotomy was performed in 43 patients, 
Table 1  Baseline demography, 
injury pattern, pre-hospital, 
ED and laboratory data for the 
cohorts
Categorical data presented as numbers with proportions of cases for each column. Continuous data pre-
sented as median (interquartile range) or mean  ±  standard deviation depending on the distribution. The 
total number of reported cases for each variable is presented in parentheses in each row
All Survivors Fatalities P
N 96 41 55
Demography
 Age/years (total = 84) 52 ± 22 51 ± 20 54 ± 23 0.280
 Age <60 years n (%) (total = 49) 49 (58%) 25 (64%) 24 (53%) 0.318
 Age >60 years n (%) (total = 35) 35 (42%) 14 (36%) 21 (47%)
 Male/n (%) (total = 96) 65 (68%) 29 (69%) 36 (67%) 0.805
Pre-morbid health (total = 58)
 Co-morbid n (%) 27 (47%) 15 (60%) 12 (36%) 0.074
 No co-morbidity n (%) 31 (53%) 10 (30%) 21 (64%)
Injury mechanism (total = 95)
 Blunt/n (%) 84 (88%) 35 (85%) 49 (91%) 0.257
 Penetrating/n (%) 9 (10%) 4 (10%) 5 (9%)
 Mixed/n (%) 2 (2%) 2 (5%) 0 (0%)
Injury pattern and location
 ISS/median IQR (total = 82) 41 (29–50) 34 (20–42) 41 (34–51) 0.001
 Thorax/n (%) (total = 96) 25 (26%) 4 (10%) 21 (39%) 0.001
 Abdomen/n (%) (total = 96) 57 (59%) 26 (62%) 31 (57%) 0.656
 Pelvis/n (%) (total = 96) 44 (46%) 19 (45%) 25 (46%) 0.918
 Head injury/n (%) (total = 91) 36 (40%) 12 (30%) 24 (47%) 0.099
Pre-hospital data
 CPR/n (%) (total = 91) 18 (20%) 5 (13%) 13 (25%) 0.149
 SBP <80 mmHg/n (%) (total = 50) 29 (58%) 10 (46%) 19 (68%) 0.111
 SBP >80 mmHg/n (%) (total = 50) 21 (42%) 12 (55%) 9 (32%)
 GCS <8/n (%) (total = 75) 28 (37%) 7 (24%) 21 (46%) 0.061
 GCS >8/n (%) (total = 75) 47 (63%) 22 (76%) 25 (54%)
Emergency department data
 CPR/n (%) (total = 79) 11 (14%) 3 (9%) 8 (18%) 0.220
 SBP <80 mmHg/n (%) (total = 65) 43 (66%) 19 (60%) 24 (73%) 0.255
 SBP >80 mmHg/n (%) (total = 65) 22 (34%) 13 (41%) 9 (27%)
Laboratory data on admission
 Hb/g/L/mean Std (total = 85) 10.0 ± 2.4 10.4 ± 2.3 9.6 ± 2.5 0.211
 pH/median IQR (total = 76) 7.20 (7.05–7.34) 7.30 (7.14–7.39) 7.13 (6.99–7.27) 0.001
 Base deficit/mean Std (total = 46) −11.0 ± 9.3 −9.0 ± 5.7 −12.8 ± 11.6 0.038
 Lactate/mmol/l/median IQR (total = 45) 8.1 (4.3–13.8) 6.6 (3.4–9.9) 10.6 (5.6–15.0) 0.066
 INR/median IQR (total = 51) 1.3 (1.2–1.7) 1.2 (1.1–1.4) 1.5 (1.3–2.4) 0.001
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embolization in 42, and brain surgery in 15. No interven-
tion could be made in 9 patients (Table 3).
The transfusion requirement for the first 24  h after 
REBOA placement shows a median of 7 U PRBC (IQR 
3–14, 1 unit PRBC appr 300 ml), 8 U FFP (IQR 4–13, 1 unit 
FFP appr 250 ml), and 1 U PLT (IQR 0–2, 1 unit 250 ml) 
(Table 3).
Continuous vs. non‑continuous occlusion 
and complications
The clinician in charge decided whether to use CO or NCO 
REBOA, probably according to the circulatory status of 
the patient. There were no significant differences between 
CO and NCO occlusion groups regarding demography, sex, 
Table 2  REBOA specific data
All Survivors Fatalities P
n 96 41 55
Location of REBOA (total = 88)
 Emergency room/n (%) 58 (66%) 24 (63%) 34 (68%) 0.608
 Operating room/n (%) 14 (16%) 6 (16%) 8 (16%)
 Hybrid operating room/n (%) 14 (16%) 6 (16%) 8 (16%)
 Intensive care unit/n (%) 1 (1%) 1 (3%) 0
 Other/n (%) 1 (1%) 1 (3%) 0
SBP
 SBP before inflation/median IQR (total = 88) 60 (40–80) 70 (54–88) 50 (0–74) 0.006
 SBP after inflation/median IQR (total = 89) 100 (80–128) 111(91–135) 95 (65–125) 0.029
Puncture technique (total = 85)
 Landmark guided/n (%) 71 (84%) 34 (92%) 37 (77%) 0.073
 Ultrasound guided/n (%) 5 (6%) 1 (3%) 4 (8%)
 Fluoroscopy guided/n (%) 3 (3.5%) 2 (5%) 1 (2%)
 Cut-down/n (%) 6 (7%) 0 6 (13%)
Specialty obtaining access (total = 90)
 ED/ICU/n (%) 60 (67%) 29 (74%) 31 (61%) 0.405
 Vascular surgeon/n (%) 20 (22%) 8 (21%) 12 (24%)
 General surgeon/n (%) 3 (3%) 0 3 (6%)
 Radiologist/n (%) 6 (7%) 2 (5%) 4 (8%)
Attempts at arterial access (total = 58)
 1/n (%) 32 (55%) 13 (54%) 19 (56%) 0.526
 2–3/n (%) 21 (36%) 10 (42%) 11 (32%)
 >3/n (%) 5 (9%) 1 (4%) 4 (12%)
Zone of occlusion (total = 92)
 Zone 1/n (%) 86 (94%) 37(93%) 49 (94%) 0.674
 Zone 2/n (%) 3 (3%) 2 (5%) 1 (2%)
 Zone 3/n (%) 3 (3%) 1 (3%) 2 (4%)
Total occlusion time (total = 73) [min/n (%)]
 <30 26 (36%) 15 (48%) 11 (26%) 0.147
 31–60 26 (36%) 9 (29%) 17 (41%)
 >60 21 (29%) 7 (23%) 14 (33%)
 <40 38 (52%) 19 (61%) 19 (45%) 0.175
 >40 35 (48%) 12 (39%) 23 (55%)
Complications
 Balloon migration/n (%) (total = 90) 4 (4%) 3 (8%) 1 (2%) 0.208
 Balloon rupture/n (%) (total = 90) 3 (3%) 1 (3%) 2 (4%) 0.751
 Extremity compartment syndrome/n (%) (total = 42) 3 (7%) 3 (19%) 0 0.022
 Signs of embolization/n (total = 85) 3 (4%) 1 (3%) 2 (4%) 0.657
 Aortic/iliac rupture/n (total = 61) 0 0 0
 Access site bleeding/n (total = 82) 0 0 0
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mechanism of injury, ISS, prehospital GCS or occlusion 
time (Table 4). However, SBP before inflation and after 
inflation were higher in the NCO REBOA than in the CO 
REBOA group (p < 0.05) (Fig. 2).
No major complications, such as bleeding from the 
REBOA access site or aorta perforation, were reported 
(Table 2). In the NCO group there were no reported cases 
with extremity compartment syndrome, but 3 cases were 
reported in the CO group. This was due to the sheath place-
ment in 2 of the cases. Balloon migration and balloon rup-
ture were reported in 5 cases in the NCO, and 2 cases in 
the CO group. Distal embolization was reported in 2 CO 
cases and 1 NCO case. There were 2 cases in the CO group 
with signs of distal embolization and 1 case in the NCO 
group. Multiple organ failure (MOF) was reported in 6 of 
18 reported cases in the CO and 4 of 11 reported cases in 
NCO group (Table 4).
Mortality
The median stay at the intensive care units was 5 days (IQR 
2–7) for survivors and 0 days (IQR 0–1) for fatalities. The 
overall 30-day mortality was 56% (Table 3). There was no 
significant difference regarding mortality between patients 
older and younger than 60 years (Table 1). The 30-day 
mortality for the NCO group was 48%, and for the CO group 
64% (Table 4).
Discussion
The current study presents the initial 24-months experience 
of a global registry effort to assess the efficacy of aortic bal-
loon occlusion in trauma patients. The registry reports a total 
of 96 patients recruited. The majority of the reported cases 
were blunt trauma with high ISS and age with a 30 days 
mortality of 64% for CO and 48% for NCO patients. This 
observational report presents interesting data on the manage-
ment of extra-thoracic hemorrhage and non-compressible 
torso hemorrhage, and gives is the first registry data on con-
tinuous and non-continuous REBOA use.
The current study confirms and extends the findings of 
the only other published REBOA-specific registry, which is 
from North America. The prospective observational Aortic 
Occlusion for Resuscitation in Trauma and Acute Care Sur-
gery (AORTA) demonstrated a mortality among REBOA 
patients (n = 46) of 72%, and among RT patients (n = 68) 
of 84% [13]. The AORTA registry aims to compare the two 
existing aortic occlusion techniques (REBOA vs. RT and 
aortic clamping) in traumatic and acute surgery patients in 
hemorrhagic shock. There are no prospective multicenter 
Table 3  Data relating to 
imaging, modality of definitive 
hemorrhage control and 
resuscitation
All Survivors Fatalities P
n 96 41 55
Disposal from ED (total = 96)
 Operating room/n (%) 25 (26%) 10 (24%) 15 (28%) 0.839
 CT/n (%) 10 (10%) 6 (14%) 4 (7%)
 Angio suite/n (%) 4 (4%) 1 (2%) 3 (6%)
 ICU/n (%) 2 (2%) 1 (2%) 1 (2%)
 Hybrid operating room/n (%) 12 (13%) 6 (14%) 6 (11%)
Hemorrhage control intervention
 Laparotomy/n (%) (total = 96) 44 (46%) 23 (55%) 21 (39%) 0.122
 Thoracotomy/n (%) (total = 84) 29 (35%) 3 (9%) 26 (53%) <0.001
 Angioembolization/n (%) (total = 93) 42 (45%) 20 (48%) 22 (43%) 0.666
 Pelvic external-fixation/n (%) (total = 51) 25 (49%) 13 (54%) 12 (44%) 0.488
 Brain surgery/n (%) (total = 15) 15 (100%) 3 (20%) 12 (80%)
 No intervention/n (%) (total = 96) 9 (9%) 3 (7%) 6 (11%) 0.508
Resuscitation
 PRBC/median IQR (total = 81) 7 (3–14) 8 (4–12) 6 (2–14) 0.554
 FFP/median IQR (total = 79) 8 (4–13) 8 (4–17) 8 (4–12) 0.413
 PLT/median IQR (total = 74) 1 (0–2) 2 (1–2) 1 (0–2) 0.052
ICU care
 Days/median IQR (total = 73) 1 (0–5) 5 (2–7) 0 (0–1) <0.001
 Multiple organ failure/n (%) (total = 29) 10 (35%) 2 (18%) 8 (44%) 0.149
30-day mortality
 n (%) (total = 96) 54 (56%) 0
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Table 4  Comparison of continuous- to non-continuous REBOA
Continuous REBOA Non-continuous REBOA P
n 50 46
Demography
 Male/n (%) (total = 96) 35 (70%) 30 (65%) 0.617
 Age/mean Std (total = 84) 54 ± 25 51 ± 18 0.403
Mechanism of injury (total = 95)
 Blunt/n (%) 42 (86%) 42 (91%) 0.365
 Penetrating/n (%) 5 (10%) 4 (9%)
ISS
 Median (IQR) (total = 82) 41 (30–54) 38 (26-50) 0.255
Occlusion Time (total = 73) [min/n (%)]
 <30 13 (46%) 13 (29%) 0.083
 31–60 11 (39%) 15 (33%)
 >60 4 (14%) 17 (38%)
Pre-hospital data
 GCS < 8/n (%) (total = 75) 13 (41%) 15 (35%) 0.611
 CPR/n (%) (total = 91) 11 (23%) 7 (16%) 0.370
Systolic blood pressure
 ED Admission < 80 mmHg/n (%) (total = 65) 22 (67%) 21 (66%) 0.929
 SBP mm Hg before inflation/median (IQR) (total = 88) 50 (0–70) 68 (43–88) 0.026
 SBP mmHg after inflation/median (IQR) (total = 89) 95 (69–120) 110 (90–135) 0.022
Laboratory data on admission
 ED Lactate/median (IQR) (total = 45) 8.5 (4.2-13.0) 7.4 (4.5–13.8) 0.890
 ED Base deficit/mean Std (total = 46) −11.4 ± 10.0 −10.3 ± 8.2 0.426
 ED INR/median (IQR) (total = 51) 1.4 (1.2–1.8) 1.2 (1.1–1.6) 0.078
Complications
 Extremity compartment syndrome/n (%) (total = 42) 3 (11%) 0.0 0.180
 Balloon migration/n (%) (total = 90) 1 (2%) 3 (7%) 0.285
 Balloon rupture/n (%) (total = 90) 1 (2%) 2 (5%) 0.531
 Signs of embolization/n (%) (total = 85) 2 (4%) 1 (3%) 0.628
 MOF/n (MOF/total) (total = 29) 6 (6/18) 4 (4/11) 0.868
Mortality
 n (%) (total = 96) 32 (64%) 22 (48%) 0.111
Fig. 2  Pre- and post-REBOA 
systolic blood pressures for 
all patients (n = 88), survivals 
(n = 40), fatalities (n = 49), 
continuous-REBOA (CO-
REBOA, n = 44) and non-
continuous-REBOA (NCO-
REBOA, n = 45)
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clinical studies with a large collection of patients described 
so far. The AORTA patients had a median ISS of 31; a 
majority were injured by a blunt mechanism (62%); and 
60% were hypotensive (SBP <90 mmHg). They are similar 
to the patients in our cohort but with less blunt trauma (62 
vs. 88%).
The development and evolution of these registries have 
been driven by a variety of factors, both experimental and 
clinical. Translational large-animal studies of REBOA have 
shown promising results in the management of hemorrhagic 
shock. REBOA has been shown to increase mean arterial 
pressure (MAP), decrease the hemorrhage, and reduce the 
fluid resuscitation volume. Histologic analysis shows a trend 
toward cardiac and visceral organ damage with occlusion 
time longer than 60 min [14–18]. In these studies, no aortic 
injury [14, 15] or necrosis of cerebral or spinal cord has been 
reported [17].
However, the clinical picture is less clear. The greatest 
experience worldwide is from Japan, where the Japanese 
National Trauma Databank (JTDB) has been capturing 
trauma data, including some REBOA data, for many years. 
Norii et al. and Inoue et al. have retrospectively compared 
REBOA and non-REBOA patients regarding mortality 
[19, 20]. These studies include a great number of patients 
(Norii n = 452) (Inoue n = 625) and adjusted the likeli-
hood of receiving REBOA with propensity score analysis 
to match with non-REBOA patients. The studies conclude 
that REBOA is associated with higher mortality. Norii et al. 
calculated a mortality of 76% in REBOA patients. Inoue 
et al. reported an in-hospital mortality of 62% for REBOA 
versus 45% for non-REBOA patients.
The findings from these studies are also dependent upon 
the denominator. A further retrospective paper from Japan 
by Abe et al. [21] (n = 152) demonstrated that REBOA 
may indeed be superior to RT. The study’s endpoint was in-
hospital mortality, which turned out to be 73% in REBOA 
patients and 91% in RT patients, respectively, similar to the 
AORTA study’s mortality. The authors mention differences 
in interventions performed in each group and the fact that 
the REBOA group had less severe thoracic injuries than the 
patients in the aortic cross-clamping group.
The Japanese studies from the JTDB have collected large 
cohorts. However, the JTDB is not REBOA or open aortic 
cross clamping oriented, and therefore lacks specific data 
related to aortic occlusion. The studies are retrospective 
and use propensity score matching and analysis to predict 
outcome after specific exposure. The risk with this meth-
odology is that there are many confounding factors causing 
difficulty in interpreting the results.
Furthermore, the Japanese experience of the harmful 
effects of REBOA does not appear to be supported by data 
from North America and Europe. The clinical series from 
Gupta et al., Brenner et al. and Hörer et al. [2, 22, 23] have 
shown good outcomes in both penetrating and blunt trauma 
patients in hemorrhagic shock. But, despite good results 
these publications are clinical series with small groups of 
patients and low levels of evidence, which makes it difficult 
to reach any solid conclusions based on their observations.
The most interesting part of the current study is the pres-
entation of non-continuous occlusion data. The current study 
demonstrates a reduced mortality, albeit not statistically 
significant, in patients treated with partial or intermittent 
techniques. The non-continuous aortic occlusion techniques 
show a generally lower mortality rate but also a lower mor-
bidity rate regarding organ failure which is the cause of late 
deaths occurring in trauma patients [24]. Notably, compart-
ment syndrome only occurred in the CO group. Theoreti-
cally, pREBOA has the effect of ameliorating reperfusion 
injury. This is potentially a very important finding and fur-
ther research is required to identify the optimum method for 
pREBOA.
To date, there are not many clinical studies conducted 
about partial occlusion, albeit case and technical reports [10, 
12]. The translational studies suggest that partial occlusion 
has the potential of reducing ischemic injuries [11, 25]. The 
results from non-continuous occlusion in our study should 
be carefully interpreted since there was a difference between 
the continuous and non-continuous groups in SBP before 
inflation of the balloon. In addition, estimation of the degree 
of the actual partial occlusion requires the possibility of 
measuring SBP above and below the occlusion site or blood 
flow distal to the balloon.
The registry faces a number of limitations, which should 
be discussed. With the current iteration of this registry, the 
focus has been on REBOA-specific data. Therefore, there 
is no comparison group to evaluate the efficacy of REBOA 
use, and there could be selection bias in the reported cases 
as there are no means for control of inclusion and exclusion 
of patients. It is also noted that there are missing data for 
some of the presented parameters. Other identified limita-
tions are differences in indications/policies for REBOA use 
at each center since there are no defined specifications for 
its use. A longer follow-up of morbidity and late mortality 
(3–6 months) is another modification that can be made in 
future studies.
Some of the shortcomings listed above will be addressed 
via modifications to the registry in the case of further stud-
ies. Equally, a randomized control trial is due to start in the 
UK in 2017 (the UK-REBOA Trial), which should comple-
ment some of the experiences in this early report.
The ABO trauma registry is an effort to gather interna-
tional data on the current clinical use of REBOA in trau-
matic shock. The registry gives an insight into international 
practice from a real-world perspective. Its data collection 
intends to be ongoing so further centers are encouraged to 
join and submit data.
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It is important to emphasize that REBOA is an endovas-
cular technique, which requires specific training for its man-
agement, and that it is a tool for temporary hemodynamic 
control until definitive repair. REBOA is therefore part of 
a trauma management/system, i.e. Endovascular Hybrid 
Trauma and Bleeding Management (EVTM) and should be 
used carefully [2]. In several countries, there are REBOA 
management courses but there are no standardized courses 
provided yet [26–28]. With the range of specialties involved 
in this procedure, it is now time to provide structured stand-
ardized courses such as the DCR.
Conclusion
The first 24 months of the ABO registry marks a major 
achievement in establishing a mechanism for data collection. 
Further work is required to address some of the limitations 
identified in this preliminary analysis. However, overall, 
there is accumulating evidence that REBOA is an effective 
adjunct in the control of traumatic hemorrhage, and that non-
continuous occlusion could be an alternative in particular 
cases. This adjunct can be delivered safely by a multi-dis-
ciplinary team with a low rate of procedural complications. 
Further statistical power in the registry is required before 
comments can be made regarding mortality.
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